R. Clayton
- Infectious Diseases top 2%
- Virology top 1%
- Hepatology top 2%
- Molecular Biology
- Epidemiology top 10%
- Co-authors
- Arvind H. PatelAnia M. OwsiankaAnn VosMaxwell D. CummingsSusan M. GrahamDavid BhellaPeter CherepanovS. Hare
- Topics
- HIV Research and Treatment (12 papers)HIV/AIDS drug development and treatment (12 papers)Hepatitis C virus research (7 papers)
- Partner nations
- United KingdomBelgiumSlovakia
In The Last Decade
R. Clayton
32 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 81
- Infectious Diseases 577
- Virology 507
- Hepatology 493
- Molecular Biology 471
- Epidemiology 429
Countries citing papers authored by R. Clayton
This map shows the geographic impact of R. Clayton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Clayton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Clayton more than expected).
Fields of papers citing papers by R. Clayton
This network shows the impact of papers produced by R. Clayton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Clayton. The network helps show where R. Clayton may publish in the future.
Co-authorship network of co-authors of R. Clayton
This figure shows the co-authorship network connecting the top 25 collaborators of R. Clayton. A scholar is included among the top collaborators of R. Clayton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Clayton. R. Clayton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 6 | |
| 3 | 5 | |
| 4 | 26 | |
| 5 | 29 | |
| 6 | 51 | |
| 7 | 244 | |
| 8 | 32 | |
| 9 | 82 | |
| 10 | 45 | |
| 11 | 9 | |
| 12 | 9 | |
| 13 | 60 | |
| 14 | 81 | |
| 15 | 5 | |
| 16 | 56 | |
| 17 | 2 | |
| 18 | 8 | |
| 19 | 5 | |
| 20 | 9 |
About R. Clayton
R. Clayton is a scholar working on Virology, Hepatology and Infectious Diseases, having authored 32 papers that have together received 1.4k indexed citations. Recurring topics across this work include HIV Research and Treatment (12 papers), HIV/AIDS drug development and treatment (12 papers) and Hepatitis C virus research (7 papers). The work is most often cited by research in Virology (507 citations), Hepatology (493 citations) and Infectious Diseases (577 citations). R. Clayton has collaborated with scholars based in United Kingdom, Belgium and Slovakia. Frequent co-authors include Arvind H. Patel, Ania M. Owsianka, Ann Vos, Maxwell D. Cummings, Susan M. Graham, David Bhella, Peter Cherepanov, S. Hare, Jan Willem Thuring and Lawrence D. Loomis‐Price. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.